SCHEDULE 13G/A: Wellington Management Discloses 6.48% Stake in Charles River Labs

Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, reporting a 6.48% beneficial ownership in Charles River Laboratories International, Inc. common stock.

Summary

• Wellington Management Group LLP, along with its affiliates Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP, collectively reported beneficial ownership of 3,190,467 shares of Charles River Laboratories International, Inc. common stock.
• This aggregate amount represents 6.48% of the class of securities.
• The reporting persons hold shared voting power over 2,811,985 shares and shared dispositive power over 3,190,467 shares.
• Wellington Management Company LLP, specifically, holds shared voting power over 2,720,166 shares and shared dispositive power over 2,802,313 shares, contributing to the overall group's beneficial ownership.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: The filing indicates a significant institutional ownership stake, which can be viewed positively by the market, but it is a passive disclosure without operational or financial performance details.

Positives

• The continued significant beneficial ownership by a major institutional investor like Wellington Management Group LLP can signal ongoing institutional confidence in Charles River Laboratories International, Inc.

Risks

• The reporting persons certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating potential risks associated with activist investor intentions.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of institutional ownership and does not provide specific insights into broader industry trends or competitive landscape beyond indicating continued investment in the life sciences sector.

Stakeholder Impact

• Shareholders may view the continued significant institutional ownership by Wellington Management as a sign of confidence in the company's long-term prospects.

Key Dates

Recommendation

This Schedule 13G filing primarily discloses a significant passive ownership stake by Wellington Management Group LLP and its affiliates in Charles River Laboratories International, Inc. While substantial institutional ownership can be a positive signal of confidence, the filing itself does not contain operational, financial, or strategic updates that would warrant a change in investment recommendation. It is a routine disclosure of a passive investment position, suggesting a 'hold' recommendation as it neither presents new compelling reasons to buy nor significant concerns to sell based solely on this document.

Keywords

Charles River Laboratories, Wellington Management, Institutional Ownership, SEC Filing, Schedule 13G, Common Stock, Beneficial Ownership, Investment Adviser, CRL